期刊文献+

高三酰甘油血症与冠心病 被引量:4

Hypertriglyceridemia and coronary heart disease
下载PDF
导出
摘要 高三酰甘油血症(HTG)与冠心病(CHD)的关系近年逐渐受到重视,流行病学证据表明,据HDL-c水平校正的HTG仍是CHD的危险因素。随机临床研究证实,降三酰甘油治疗可降低临床冠心病事件。富含三酰甘油的脂蛋白中有一类小而密脂蛋白与冠心病密切相关;治疗高三酰甘油血症对冠心病的防治有积极意义。 The relationship between hypertriglyceridemia (HTG) and coronary heart disease (CHD) has been gradually recognized in recent year. A recent meta-analysis has shown that HTG. even when adjusted for the HDL-C level, is a risk factor for CHD. It is clear that small and dense triglyceride-rich lipoproteins (TRLPs) are atherogenic;Triglyceridemia-lowering treatment is benefit for prevention and treatment of coronary heart disease.
出处 《中国心血管杂志》 2001年第5期301-303,共3页 Chinese Journal of Cardiovascular Medicine
关键词 高三酰甘油血症 冠心病 三酰甘油的脂蛋白 Hypertriglyceridemia Coronary heart disease Triglyceride-rich lipoproteins
  • 相关文献

参考文献14

  • 1Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol.1992.70:733-737
  • 2Jeppesea J, Hein HO, Saudicani P, et al,Triglycexide concentration and ischemic heart disease, an eight yea: follow-up in the Copenhagen male study. Circulation, 1998, 97:1029-1036.
  • 3Miller M.Seidler A.Moalemi A.et al.Normal triglyceride levels and coronary artery disease events: the Baltimore coronary observational long- term study. J Am Coil Cardiol, 1998.21:1252-1257.
  • 4Hokansoa JE, Austin MA- Plasma triglyceride level is a risk factor for cardiovascular disease independeat of high-deasity lipoprotein cholesterol level:a meta- analysis of population -based prospective studies. J Cardiovasc Risk. 1996, 3:213-219
  • 5Krauss RM. Atherogenicity of triglyceride- rich lipoproteins. Am J Cardiol, 1998, 81:13B-17B
  • 6Frick MH. Elo O, Haapa K, et al. Helsinki Heart Study:primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med, 1987, 317:1237- 1245.
  • 7Syvanna M.Nieminen MS.Frick MH.et al.Associations between lipoproteins and the progression of coronary and veingraft atheroselerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol, Circulation,1998, 98:1993-1999.
  • 8Ruotolo G.Ericsson CG.Tettamanti C.et al.Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and retationship of lipoprotein variables to progression of coronary artery disease in the Bezafibrace Coronary Atheroscterosis Intervention Trlat (BECAIT).J Am Coll Cardiol.1998.32:1648-1656.
  • 9Staels B, Dallongeville J,Auwerx J, et at, Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation, 1998, 98:2088-2093.
  • 10Shepherd .L Fibrates and stating in the treatment of hyperlipldaemia: an appraisal of their efficacy and .safety. Eur Heart J, 1995, 16:5- 13.

同被引文献36

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部